Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2005
11/10/2005WO2005083422A3 Methods and materials for tracking manmade airborne plumes
11/10/2005WO2005083394A3 Methods for detecting anionic and non-anionic proteins using carbocyanine dyes
11/10/2005WO2005075684A3 Use of organic anion transporter b in screens for candidate substrates for crossing the blood brain barrier
11/10/2005WO2005075665A3 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
11/10/2005WO2005074641A8 Variant neuronal nicotinic alpha-7 receptor and methods of use
11/10/2005WO2005073711A3 Chromatographic material for the absorption of proteins at physiological ionic strength
11/10/2005WO2005070456A3 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
11/10/2005WO2005066616A3 Biosensor and method of making
11/10/2005WO2005066612A3 Detection of biomolecules using porous biosensors and raman spectroscopy
11/10/2005WO2005065541A3 Methods for using raman spectroscopy to obtain a protein profile of a biological sample
11/10/2005WO2005064349A3 Detection cartridges, modules, systems and methods
11/10/2005WO2005063170A3 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof
11/10/2005WO2005059719A3 Calculating confidence levels for peptide and protein identification
11/10/2005WO2005059545A3 Diagnostics ans therapeutics for diseases associated with g protein-coupled receptor gpr82 (gpr82)
11/10/2005WO2005059504A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
11/10/2005WO2005057223A3 Methods for identifying modulators of active kit tyrosine kinase receptor
11/10/2005WO2005056042A3 Methods of protecting against radiation using flagellin
11/10/2005WO2005054272A3 Human immunodeficiency virus entry inhibitor assay
11/10/2005WO2005052574A3 Diagnostics and therapeutics for diseases associated with potassium channel subfamily k, member 4 (kcnk4)
11/10/2005WO2005049804A3 Engineering enzymes through genetic selection
11/10/2005WO2005047851A3 Device for measuring nanometer level pattern-dependent binding reactions
11/10/2005WO2005040790A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75)
11/10/2005WO2005025592A3 In vivo modulation of neuronal transport
11/10/2005WO2005024058A3 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
11/10/2005WO2005022143B1 Method and apparatus for assay of electrochemical properties
11/10/2005WO2005016231A3 Agents and methods for treatment of disease by oligosaccharide targeting agents
11/10/2005WO2005009222A3 Method of determining sperm capacitation
11/10/2005WO2005009202A3 Automatic identification of bioagents
11/10/2005WO2005007691A8 East coast fever vaccine based on ctl-specific schizont antigens
11/10/2005WO2004102160A3 Imaging platform for nanoparticle detection applied to spr biomolecular interaction analysis
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005WO2004050898A3 Ampk pathway components
11/10/2005WO2004048933A3 Methods for diagnosing rcc and other solid tumors
11/10/2005WO2004020970A3 α-AMYLASE ASSAY AND USES THEREOF
11/10/2005WO2003106656A3 Single domain tdf-related compounds and analogs thereof
11/10/2005WO2003101176A8 Method, composition and kit for antigenic binding of norwalk-like viruses
11/10/2005WO2003060098A3 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050251869 Animal model for raising HDL-cholesterol with niacin
11/10/2005US20050251367 Fluid monitoring systems and methods with data communication to interested parties
11/10/2005US20050251366 Monitoring systems and methods for fluid testing
11/10/2005US20050251348 Gene-to-gene graphical representation
11/10/2005US20050251347 Automatic visual recognition of biological particles
11/10/2005US20050251346 Method and apparatus for reaction route graphs for reaction mechanism and kinetics modeling
11/10/2005US20050251345 Small molecules and a pharmacophore model for inhibition of anthrax lethal factor
11/10/2005US20050251338 Method of soil geochemistry analysis prospecting
11/10/2005US20050251060 Methods of detecting gaseous component levels in a breath
11/10/2005US20050251046 Probe array producing method
11/10/2005US20050251027 Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals
11/10/2005US20050251025 Methods and systems for detection and monitoring of neurodegenerative diseases using magnetic resonance spectroscopy
11/10/2005US20050251000 Blood sugar level measuring apparatus
11/10/2005US20050250996 Biological sensor device and content playback method and apparatus
11/10/2005US20050250957 Compounds containing thiosulfate moieties
11/10/2005US20050250853 Beta-tubulin inhibitors
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250745 Biomarkers for age-related macular degeneration (AMD)
11/10/2005US20050250729 Sulfonamido derivatives with a conserved ethyl uronamide group;1-deoxy-1-[6-[[[[4-[N-(benzyl)aminosulfonyl]phenyl]amino]-carbonyl]amino]-9H-purin-9-yl]-N-ethyl- beta -D-ribofuranuronamide or derivatives; anticarcinogenic, antiinflammatory, antiischemic, antiepileptic, and hypertensive agents
11/10/2005US20050250724 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
11/10/2005US20050250722 FcgammaRIIA-specific nucleic acid interference
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250709 Anti-neoplastic agents, combination therapies and related methods
11/10/2005US20050250700 KDR and VEGF/KDR binding peptides
11/10/2005US20050250690 Leptin peptide antagonists
11/10/2005US20050250673 Neurodegenerative disease treatment
11/10/2005US20050250222 Method for measuring trace amount of material by use of quarts resonator
11/10/2005US20050250221 With the use of magnetic beads; used for analysis of the gene structure or gene sequence; increased total surface area of the magnetic beads, which area is available for binding of the analyte
11/10/2005US20050250220 Isoelectric particles and uses thereof
11/10/2005US20050250216 Automated high-throughput solubility screening of organic compounds by combustion analysis using CO2 detection
11/10/2005US20050250215 Measurement of melanocortin peptides and uses thereof
11/10/2005US20050250214 Zinc binding compounds and their method of use
11/10/2005US20050250213 Preparation of a calibration matrix using an analytical technique to identify the type and quantity of fatty acids in a baseline reference material, and relating the results to the spectral data obtained from Fourier Transform Near Infrared spectroscopy of said baseline reference material; food analysis
11/10/2005US20050250212 Preparation of a calibration matrix using an analytical technique to identify the type and quantity of fatty acids in a baseline reference material, and relating the results to the spectral data obtained from Fourier Transform Near Infrared spectroscopy of said baseline reference material; food analysis
11/10/2005US20050250209 Determining metal content of source rock during well logging
11/10/2005US20050250204 Methods and apparatus for separation of particles
11/10/2005US20050250200 Testing microreactor, testing device and testing method
11/10/2005US20050250198 Biochemical measuring chip and measuring apparatus
11/10/2005US20050250195 Crystallographic structure of TcPRACA and uses therefor
11/10/2005US20050250184 Peptide hormones zalpha48 and zsig97
11/10/2005US20050250174 administering fungicides to skins of mammals that have been infected with fungi, then analyzing the efficiency by culturing segments of the skin and counting viable cells of microorganisms
11/10/2005US20050250171 Culturing cells with fluorophore-labeled protein covalently bound to vessel; high throughput screening of modulators of tumor metastasis or osteoclast differentiation
11/10/2005US20050250170 composition comprising an apo-carbonic anhydrase protein and a photoluminescent molecule selected from 4-(2-hydroxyethylthio)-7-aminosulfonyl-2,1,3-benzoxadiazole and hydroxynaphthalenesulphonamide 2; homogeneous fluorescence polarization (anisotropy) assays; detecting and quantifying ions in solution
11/10/2005US20050250168 Biological soil detector and method of using same
11/10/2005US20050250165 Test piece for measuring high-density lipoprotein (HDL) cholesterol
11/10/2005US20050250164 obtaining an epithelial cell sample suspected of being tumorigenic; identifying cells that have shed a 120-130 kD fragment of alpha -dystroglycan, presence of the fragment indicates that such cells are tumorigenic; contacting cell with a transfection agent containing a mammal dystroglycan gene
11/10/2005US20050250163 Modulators of angiogenesis and tumorigenesis
11/10/2005US20050250162 Preventives/remedies for myeloma tumor and method of diagnosing the same
11/10/2005US20050250161 inducing tolerance to xenograft tissue or organ; tolerogenic antigen presenting cells (APC) which overexpress monocyte inhibitory receptor (MIR); generating antigen specific allospecific human-suppressor CD8+CD28- T cells; detecting expression of ILT3, ILT4, ILT2 protein; autoimmune diseases; host cell
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050250159 Methods for using Raman spectroscopy to obtain a protein profile of a biological sample
11/10/2005US20050250158 Arrays of colloidal crystals
11/10/2005US20050250156 Detection of acute myocardial infarction biomarkers
11/10/2005US20050250155 Multiple marker characterization of single cells
11/10/2005US20050250154 Peptides associated with hepsin protease active site for use in identification of modulators for treatment of cell proliferative disorders
11/10/2005US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules
11/10/2005US20050250148 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
11/10/2005US20050250146 Multiplexed detection of e.g., bacteria, viruses, and biological toxins utilizing two markers for each agent; the presence or absence in a sample of each of the two markers per agent is determined in separate reactions; however each reaction is used to detect a single marker for multiple agents
11/10/2005US20050250141 Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots
11/10/2005US20050250140 Probe array
1 ... 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 ... 3937